皇隆制药 (834298.OC)

+ 收藏

现金流量表(皇隆制药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 201,080,312.43412,445,088.24207,738,250.10452,281,158.10171,350,896.33
 收到的税费返还(元) 31,030.521,044,169.4838,698.524,170,582.753,822,053.93
 收到其他与经营活动有关的现金(元) 15,483,939.8767,776,532.3256,878,922.9140,868,954.8451,036,895.49
 经营活动现金流入小计(元) 216,595,282.82481,265,790.04264,655,871.53497,320,695.69226,209,845.75
 购买商品、接受劳务支付的现金(元) 40,373,223.49129,919,847.1959,926,133.60149,520,638.7665,319,222.16
 支付给职工以及为职工支付的现金(元) 36,148,472.9169,853,766.2239,067,466.2769,726,351.4236,992,989.28
 支付的各项税费(元) 15,750,597.3636,425,664.4925,074,748.5434,866,662.4913,292,224.32
 支付其他与经营活动有关的现金(元) 97,698,696.43226,069,179.88116,672,956.01215,861,584.21101,424,834.68
 经营活动现金流出小计(元) 189,970,990.19462,268,457.78240,741,304.42469,975,236.88217,029,270.44
 经营活动产生的现金流量净额(元) 26,624,292.6318,997,332.2623,914,567.1127,345,458.819,180,575.31
二、投资活动产生的现金流量
 收回投资收到的现金(元) -760,016.29680,016.2920,000.00-
 取得投资收益收到的现金(元) -40,944.1640,944.1636.61-
 处置固定资产、无形资产和其他长期资产收回的现金净额(元) 9,500.0077,000.0020,000.00145,500.00130,700.00
 收到其他与投资活动有关的现金(元) -88.9088.90--
 投资活动现金流入小计(元) 9,500.00878,049.35741,049.35165,536.61130,700.00
 购建固定资产、无形资产和其他长期资产支付的现金(元) 38,702,617.57119,153,130.4260,608,577.4966,776,702.7418,593,158.43
 投资支付的现金(元) ---1,780,000.001,750,000.00
 投资活动现金流出小计(元) 38,702,617.57119,153,130.4260,608,577.4968,556,702.7420,343,158.43
 投资活动产生的现金流量净额(元) -38,693,117.57-118,275,081.07-59,867,528.14-68,391,166.13-20,212,458.43
三、筹资活动产生的现金流量
 取得借款收到的现金(元) 69,750,000.00432,900,000.00115,000,000.00393,000,000.00122,000,000.00
 筹资活动现金流入小计(元) 69,750,000.00432,900,000.00115,000,000.00393,000,000.00122,000,000.00
 偿还债务支付的现金(元) 51,470,000.00344,310,000.0095,800,000.00342,123,800.00100,146,760.58
 分配股利、利润或偿付利息支付的现金(元) 7,041,639.0014,139,818.717,663,298.3714,978,272.757,096,186.50
 筹资活动现金流出小计(元) 58,511,639.00358,449,818.71103,463,298.37357,102,072.75107,242,947.08
 筹资活动产生的现金流量净额(元) 11,238,361.0074,450,181.2911,536,701.6335,897,927.2514,757,052.92
四、汇率变动对现金及现金等价物的影响(元) -0.21-0.52-
五、现金及现金等价物净增加额(元) -830,463.94-24,827,567.31-24,416,259.40-5,147,779.553,725,169.80
 加:期初现金及现金等价物余额(元) 64,957,673.6889,785,240.9990,057,621.6694,933,020.5494,933,020.54
 期末现金及现金等价物余额(元) 64,127,209.7464,957,673.6865,641,362.2689,785,240.9998,658,190.34
补充资料:
 净利润(元) 8,974,048.88-36,190,937.896,111,366.22-15,961,599.381,252,763.25
 资产减值准备(元) -1,003,011.762,200,132.152,503,864.59-1,580,012.38-855,610.18
 固定资产和投资性房地产折旧(元) 11,025,151.3532,939,225.4616,133,240.0631,785,950.8915,906,456.84
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) 11,025,151.3532,939,225.4616,133,240.0631,785,950.8915,906,456.84
 无形资产摊销(元) 328,406.91727,709.65393,954.361,382,391.15699,924.53
 长期待摊费用摊销(元) 3,155,729.684,921,467.282,359,180.564,630,553.572,312,307.34
 处置固定资产、无形资产和其他长期资产的损失(元) -16,291.36-45,727.753,991.92847,202.80638,462.77
 固定资产报废损失(元) -78,084.47---
 财务费用(元) 6,640,941.2314,006,430.387,129,212.2714,950,478.757,096,186.50
 投资损失(元) 283,627.94215,367.03-362,317.73-
 递延所得税(元) 872,480.94-1,695,345.99156,675.04737,672.45-592,309.48
  其中:递延所得税资产减少(元) 872,480.94-1,695,345.99156,675.04737,672.45-592,309.48
 存货的减少(元) 15,578,622.29-8,423,643.33-13,974,273.94-20,868,187.73-10,668,344.55
 经营性应收项目的减少(元) -17,065,369.94-13,761,179.98-26,585,002.66-32,693,971.06-19,688,806.51
 经营性应付项目的增加(元) -4,517,181.3926,095,618.4531,714,829.8439,717,187.9712,700,608.36
 现金的期末余额(元) 64,127,209.7464,957,673.6865,641,362.2689,785,240.9998,658,190.34
 减:现金的期初余额(元) 64,957,673.6889,785,240.9990,057,621.6694,933,020.5494,933,020.54
 现金及现金等价物的净增加额(元) -830,463.94-24,827,567.31-24,416,259.40-5,147,779.553,725,169.80
公告日期 2024-08-282024-04-302023-08-252023-04-282022-08-24
审计意见(境内) 带强调事项段的无保留意见带强调事项段的无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院